German medical technology firm Brainlab has introduced a new software called ‘Elements Automatic Brain Metastases Planning’, claimed to simplify stereotactic radiosurgery planning for metastatic brain tumours.
The software is the newest addition to the Elements A La Carte software portfolio in radiotherapy / radiosurgery division.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Brainlab president and CEO Stefan Vilsmeier said: "When a patient develops more than one metastasis in the brain, one of the best treatment options available, radiosurgery, becomes impractical because the treatment time increases at the same rate as the number of metastases.
"With our new technology, we are poised as a company to shift the treatment paradigm and provide more treatment options and a consistent way to deliver them."
By using the new software, a group of metastases are automatically selected in such a way that the ‘multi-leaf collimator,’ or treatment beam shaper, fits to the shapes of these selected targets without leaving gaps.
An optimised ‘volumetric conformal’ radiosurgery plan will be generated by the algorithm within minutes after all metastases have been outlined and the clinical user can focus on reviewing and approving the plan in various innovative and comprehensive views.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe company said that with the new treatment concept, the software creates an optimised dose distribution whether one or ten metastases are being treated.
University of Texas Health Science Center chief medical physicist Niko Papanikolaou said: "The Brainlab automated brain metastases planning software enables a ‘monitor-unit’, and time-efficient treatment planning and delivery, while reducing the dose to healthy brain tissue.
"This novel approach to the treatment of metastatic brain tumours from Brainlab can potentially benefit several patients that are currently receiving whole brain radiation.
"We can now plan and treat metastatic brain cancer, for patients with larger volumes and higher number of metastases without the anticipated association of a decline in neurocognitive function."
The new software brings to market technology that consistently and rapidly generates radiosurgery plans for the efficient treatment of multiple metastases.
Image: Automatic brain metastases planning software by Brainlab. Photo: courtesy of Business Wire.
